Dyno Therapeutics
Dyno Therapeutics
Claim
Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Us Show More
Alpha Score
$ 109.09 M
Alpha Score
56.0
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0